Lurbinectedin for Neuroendocrine Tumors (NETs)
October 6, 2023
PRESS RELEASE: On June 14, 2023, a new editorial was published in Oncoscience, entitled, “Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer.” continue reading »